All Type of News
Government mulls introduction of reference price system
The government is considering implementing a reference price system (RPS) by stages in a bid to complement the current new pricing policy, an official of the Ministry of Health, Welfare and Family Affairs said in a lo...
KRPIA to support scientific events by third party
The controversial third-party support for scientific events may subdue as member companies of the KRPIA seem to be positive.
Changing their negative response over the issues, the KRPIA expressed an intension to col...
Government urged to evaluate patient's access
The Korean government needs to evaluate the effectiveness of new medicines in terms of patient's access, in addition to innovative concept and clinical significance, according to a report released by the Korea Institu...
KFDA warns methylphenidate abuse
The KFDA has issued a warning that methylphenidate may lead to an increase risk of psychiatric side effects as young students used to take this medicine frequently to boost their study achievements.
It instructed p...
Seo named Novartis Asia-Pacific managerSeo Sang-ok, chief director of Novartis Korea, has been appointed as manager of Novartis's Asia and Pacific unit in Singapore for one year ranging from March this year to Februa...
|
Roche Korea file suit to nullify price reduction of Rocephin
Roche Korea says filed a lawsuit against the Ministry of Health, Welfare and Family Affairs to nullify the government's decision to lower the insurance price of Rocephin (ceftriaxone), a third-generation cephalosporin...
Health ministry unveils outcome-oriented welfare reforms
Vowing to set the basic format of a achievement-oriented social welfare reform, Minister of Health, Welfare and Family Affairs Kim Soung-yee announced his plans to carry out landmark reforms in the nation's health and...
Pharmaceutical firms staging all-out efforts to boost OTC sales
Influenced by sluggish sales of over-the-counter products, domestic pharmaceutical firms are grappling with their first-quarter sales target by stepping up OTC sales.
To cope with tepid domestic demand, a number of...
Dong-A to launch 9 biological products by 2013
Dong-A Pham plans to launch nine biological drugs by 2013 with hope of acquiring large shares in the global market.
To that end, the company will conduct clinical trials for six biological products to treat various...
SymBio targets cancer patch marketJapanese company SymBio has landed a Korean partner for its novel transdermal patch for chemotherapy-induced nausea, the firm's first patch product with ambitions to steal a siz...
|
